Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The 65 kDa phosphoprotein (pp65), encoded by the UL83 gene, is the most abundant tegument protein of Human Cytomegalovirus (HCMV) and a critical factor in viral pathogenesis (UniProt P06725). It primarily functions as an immune modulator, subverting the host's innate immune response by inhibiting the activation of interferon regulatory factor 3 (IRF3) and the cGAS-STING pathway, thereby preventing the production of type I interferons (, 29263269). Additionally, pp65 acts as a scaffold protein during viral assembly, facilitating the incorporation of other tegument proteins into the virion. Due to its high abundance and immunodominance, pp65 is a major target for both humoral and cellular immune responses, making it a central antigen in the development of CMV vaccines and adoptive T-cell therapies. In clinical settings, the pp65 antigenemia assay is a widely used biomarker for the rapid diagnosis and monitoring of CMV infection in immunocompromised patients, such as transplant recipients. Furthermore, the expression of pp65 in certain malignancies like glioblastoma has positioned it as a novel target for cancer immunotherapy.
Induction of antigen-specific cellular immune responses (CD4+ and CD8+ T cells) via MHC presentation of pp65-derived peptides; experimental small molecule inhibition of pp65 phosphorylation or protein-protein interactions to disrupt viral immune evasion and assembly.
5 more in the full profile.
Source types: Peer-reviewed publication · Government or health-agency page. Sources are available to Gosset users. Log in to see them.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 65 kDa phosphoprotein (pp65) (pp65).